Results

Total Results: 1,313 records

Showing results for "size".

  1. effectivehealthcare.ahrq.gov/system/files/docs/acute-diverticulitis-topic-nomination.pdf
    August 13, 2018 - that the evidence base for a clinical topic of interest likely grows exponentially over time, the size … See Table 2, Feasibility Column, Size/Scope of Review Section for the citations of included studies. … 08/2013-08/2018) KQ2: Diagnostic imaging Total number of identified systematic reviews: 0 Size … : Prevention of recurrence Total number of identified systematic reviews: 1 • Cochrane: 118 Size … /scope of review: We estimate that the total size of the relevant literature may be approximately 108
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
    March 01, 2014 - ACOS = Adverse Cough Outcome Survey; CQLQ = Cough-specific Quality of Life Questionnaire; ES = effect size … antitussive (other) Insufficient SOE 4 studies; 274 subjects Mucolytics had much smaller effect size … antitussive (opiate) Insufficient SOE 4 studies; 274 subjects Mucolytics had much smaller effect size … ) in children with chronic cough, but the study’s applicability was limited in terms of its sample size … CQLQ--corrected sample size and correlation coefficients for French 2002 paper for Repeatability. 3.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - Also unchanged during this period was the size of the Medicare FFS Parts A/B pool of enrolled beneficiaries … Figure 1: Size of the ESA user population, by kidney disease group JUL 06 JAN 07 JUL 07 JAN 08 JUL … Use Among Medicare’s Cancer Population With and Without Concomitant Kidney Disease In examining the size … During the study period, the size of the cancer and dialysis group remained stable, the cancer only group … ou sa nd s) Cancer only Cancer & intermittent KD Cancer & predialysis Cancer & dialysis Figure 3: Size
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
    August 10, 2010 - Sample size There are no restrictions for study sample size. … include study characteristics (e.g., first author, country of research origin, study design, sample size … treatment(s), age of first diagnosis, etc), study outcomes (both of benefit and of harm), sample size … impact of key methodological study limitations, in particular 1) percent of withdrawals, 2) sample size
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
    August 05, 2010 - applicable: i Groups of patients enrolled ii Type of positional MRI used iii Study design and size … (first author name, journal and year of publication), study design, condition being studied, study size … settings of test use, where the each study will be represented by a circle proportional to the study size … retrospective; cross-sectional, case-control or longitudinal; single center or multicenter) and study sample size
  6. effectivehealthcare.ahrq.gov/sites/default/files/ebc_challenge_faq.pdf
    January 01, 2010 - We can accept via email the following supported attachments with a file size not exceeding 30 megabytes … If the planned product solution for submission exceeds a file size of 30 megabytes and is a supported
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
    June 01, 2016 - of Evidence From the Systematic Review1 »ü Propranolol and steroids are effective in reducing the size … (See Table 1.) »ü Propranolol is more effective than steroids in reducing the size of IH lesions.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
    December 23, 2014 - will become apparent in most patients in the first few weeks of life and reach 80 percent of total size … Specific disease characteristics, such as lesion size, location and persistence and modifiers such as … What characteristics of the hemangioma (e.g., subtype, size, location, number of lesions) indicate risk … angiotensin- converting enzyme inhibitors, and antiangiogenic agents Intermediate Outcomes • Size … ulceration § Psychological impact on the patient Harms* Intermediate Outcomes • Size
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide-2nd-edition_disposition-comments.pdf
    March 03, 2010 - Is this a general comment, or a specific comment on inadequate sample size? … 7, Design Considerations: This information is important both for designing registries (for study size … Some information on background rates is needed to do sample size calculations, but the information may … ascertainment (and ascertainment of events without respect to exposure status) with adequate sample size … There is a strong interplay between representativeness, patient recruitment, sample size and power,
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
    August 01, 2012 - The sample size of the studies ranged from 336 to 1613. 9 The included studies compared conventional … The single randomized, controlled trial had too small of a sample size and too short of a follow up … Or 2) a trial not published in the above top 5 journals but have a sample size of at least triple the … Change in effect size of at least 50% (B2) Refers to a situation in which the new result indicates … a relative change in effect size of at least 50%.
  11. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
    August 09, 2021 - for a number of tumor features that were included in clinical trials of PBI, such as larger tumor size … challenge for clinicians in determining the optimal treatment approach, as the total dose, fraction size … ethnicity • Socioeconomic status • Area Deprivation Index • DCIS vs. invasive disease • Breast size … • BMI • Cup size • Breast implants • Mental health comorbidities • Menopausal status • Receipt … (i.e., sentinel lymph node biopsy, axillary lymph node dissection, none) • Tumor grade • Tumor size
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
    September 01, 2016 - What were the differences, if any, in pre-specified outcome measures, statistical plan and size of … Reasons for delays (if any) Population Total enrollment, sample size in each arm, drop-outs Participants … What were the differences, if any, in pre-specified outcome measures, statistical plan and size of
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_executive.pdf
    May 01, 2011 - We calculated a standardized effect size (Hedges g) to facilitate comparison of effect sizes across … We used Stata 11.2® for all effect size calculations and meta-analyses (Stata Corp., College Station … Another trial with a very intensive intervention reported a very large effect size at 2- and 4-week … We could identify few components that had a clear impact on effect size. … These analyses were purely exploratory and did not account for effect size, so should be considered
  14. effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
    April 28, 2017 - o Size/scope of review: We identified 17 studies relevant to the key questions. … See Table 2, Feasibility Column, Size/Scope of Review Section for the citations of included studies. … Total number of completed and in- progress systematic reviews: 1  Other (in process): 15 Size/scope … Total number of completed and in- progress systematic reviews: 0 Size/scope of review Relevant … o Size/scope of review: We identified 17 studies relevant to the key questions.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
    April 28, 2017 - o Size/scope of review: We identified 17 studies relevant to the key questions. … See Table 2, Feasibility Column, Size/Scope of Review Section for the citations of included studies. … Total number of completed and in- progress systematic reviews: 1  Other (in process): 15 Size/scope … Total number of completed and in- progress systematic reviews: 0 Size/scope of review Relevant … o Size/scope of review: We identified 17 studies relevant to the key questions.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
    January 01, 2005 - similar to an odds ratio that measures strength of association in an observational study or effect size … However, contrary to the typical effect size magnitudes of such odds ratios (often between 0.5 and 2
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
    February 11, 2013 - (for instance the effect size for the study that I authored required additional data for a meta-analysis … study (Kemp, Drummond & McDermott, 2010), I have attached additional data which may assist with effect size … similar studies, or varied outcome reporting, to explain that qualitative analysis was done, that effect size … Sample size should have been given much greater weight in determination of strength of evidence.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dementia-nursing-home-characteristics_executive.pdf
    October 01, 2012 - affiliation (e.g., chain, hospital, continuing care retirement community), location (urban vs. rural), size … Wrong PICOTS: 301 Wrong publication type/study design: 289 Wrong country: 132 Small sample size … A personalized assessment and treatment intervention reduced resident discomfort with an effect size … Quality of life did not differ based on proprietary status, chain affiliation, size, age, percentage … • Employ rigorous methodologies that overcome bias, and use samples of sufficient size to provide
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
    January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
    June 30, 2016 - Commentator & Affiliation Section Comment Response Public- Annonymous Findings How does sample size … than diabetes thus making it much more difficult to conduct a study that has a large enough sample size … The sample size does not affect our calculation. … Physician Office Visit: Study Size 8,000 Office and E-Visits From The Washington Post, 1/21/2013 … As noted in the technical brief, the size and scope of healthcare delivery in a virtual sense has

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: